Atara Biotherapeutics (ATRA) Return on Capital Employed Growth (1y) (2015 - 2026)
Atara Biotherapeutics (ATRA) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Atara Biotherapeutics | 141.08 Mn | 124.53 Mn | 439,000.00 | -12,715.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12,715.00 |
| Mar 31, 2026 | -806.00 |
| Dec 31, 2025 | -61,327.00 |
| Sep 30, 2025 | -33,549.00 |
| Jun 30, 2025 | -253,888.00 |
| Mar 31, 2025 | -155,321.00 |
| Dec 31, 2024 | 175,255.00 |
| Sep 30, 2024 | 71,541.00 |
| Jun 30, 2024 | 271,543.00 |
| Mar 31, 2024 | 161,618.00 |
| Dec 31, 2023 | -69,480.00 |
| Sep 30, 2023 | -12,007.00 |
| Jun 30, 2023 | -6,846.00 |
| Mar 31, 2023 | 732.00 |
| Dec 31, 2022 | 79.00 |
| Sep 30, 2022 | -90.00 |
| Jun 30, 2022 | -626.00 |
| Mar 31, 2022 | -3,997.00 |
| Dec 31, 2021 | -2,172.00 |
| Sep 30, 2021 | -889.00 |